<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Frailty
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Frailty
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Frailty
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeremy D Walston, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kenneth E Schmader, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jane Givens, MD, MSCE
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Frailty is most often defined as an aging-related syndrome of physiological decline, characterized by marked vulnerability to adverse health outcomes. Frail older patients often present with an increased burden of symptoms including weakness and fatigue, medical complexity, and reduced tolerance to medical and surgical interventions. Awareness of frailty and associated risks for adverse health outcomes can improve care for this most vulnerable subset of patients.
        </p>
        <p>
         Although there is no gold standard for detecting frailty, multiple frailty screening tools have been developed and utilized for risk assessment and epidemiologic study.
        </p>
        <p>
         This topic will review the definitions, pathophysiology, prevalence, and diagnosis of frailty and clinical approaches that may attenuate vulnerability and relieve symptoms.
        </p>
        <p class="headingAnchor" id="H573088821">
         <span class="h1">
          PREVALENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many population-based studies of frailty have been performed using a variety of frailty measures. Although the prevalence of frailty varies with the tool used and with the population studied, prevalence in several studies in the United States ranges from 4 to 16 percent in community-dwelling men and women aged 65 and older [
         <a href="#rid1">
          1-5
         </a>
         ] and up to 43 percent of older patients with cancer [
         <a href="#rid6">
          6
         </a>
         ]. Pre-frailty (patients at risk for frailty who fulfill some, not but all, criteria for frailty) has a prevalence ranging from 28 to 44 percent in those over 65 years old [
         <a href="#rid1">
          1,4,5
         </a>
         ].
        </p>
        <p>
         A 2012 systematic review found that when frailty was defined on the basis of physical findings alone, overall prevalence in 15 studies (44,894 participants) was 9.9 percent; when psychosocial aspects were included in the definition, prevalence was 13.6 percent among eight studies (24,072 participants) [
         <a href="#rid7">
          7
         </a>
         ]. In a European study (the Survey of Health, Ageing, and Retirement in Europe [SHARE]) comparing eight frailty scales, frailty prevalence ranged from 6 to 44 percent when applied to a database of individuals aged 50 to 104 years [
         <a href="#rid8">
          8
         </a>
         ]. In a US study of people aged 90 and older, the prevalence of frailty was 24 percent for those aged 90 to 94 and 39.5 percent for those 95 and older [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         In a study in the United States of nearly 6000 community-dwelling men aged 65 and older, at an average follow-up of 4.6 years, 54.4 percent of men who were robust at baseline remained robust, 25.3 percent became pre-frail, 1.6 percent became frail, 5.7 percent died, and the remainder could not be assessed [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H47662773">
         <span class="h1">
          HEALTH CONSEQUENCES AND MORTALITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Frail older adults are less able to tolerate and adapt to stressors such as acute illness, surgical or medical interventions, or trauma than younger or non-frail older adults. This increased vulnerability contributes to increased risk for procedural complications, falls, institutionalization, disability, and death [
         <a href="#rid10">
          10
         </a>
         ]. After adjustment for comorbidities, frailty predicts hip fractures, disability, and hospitalization [
         <a href="#rid4">
          4
         </a>
         ]. Frailty also predicts adverse outcomes related to renal transplantation, general surgery (elective and emergency), and cardiac surgery interventions [
         <a href="#rid11">
          11-15
         </a>
         ]. As such, frailty in older patients is considered to be the hallmark geriatric syndrome that is a forerunner to other geriatric syndromes, including frequent falls, fractures, delirium, cognitive impairment, and incontinence.
        </p>
        <p>
         Frailty is associated with increased mortality:
        </p>
        <p>
         .
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the longitudinal Women's Health Initiative Observational Study, mortality was increased in those with baseline frailty (HR 1.71; 95% CI 1.48-1.97) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a study in men, mortality was twice as high for frail, compared with robust men (HR 2.05; 95% CI 1.55-2.72) [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a European study, mortality was best predicted by the Frailty Index and Edmonton scales, with death rates three to five times higher in cases classified as frail compared with those not classified as frail [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In analysis of data from the Longitudinal Aging Study Amsterdam, in which 2874 adults aged 64 to 84 years were followed for 21 years, frailty (defined as ≥0.25 on the 32-item frailty index) was associated with greater four-year mortality (odds ratio [OR] 2.79, 95% CI 2.39-3.26) [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a cohort study of over two  million United States veterans aged 65 years or older, the risk of suicide attempt was higher in patients with all levels of frailty (prefrailty and mild, moderate, and severe frailty) compared with those without frailty, as measured by the frailty index assessing morbidity, function, sensory loss, cognition and mood, and other functions [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CONCEPTS AND DEFINITIONS
         </span>
        </p>
        <p class="headingAnchor" id="H1471705572">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is generally recognized that the term “frailty” captures the essence of age-related vulnerability and decline, and that it can be useful in clinical practice [
         <a href="#rid18">
          18,19
         </a>
         ]. At present, there are two major conceptual frameworks for the term “frailty” that have influenced the development of multiple frailty measurement tools.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical frailty, often termed phenotypic or syndromic frailty, was developed in part to capture representative signs and symptoms (fatigue, low activity, weakness, weight loss, and slow gait) of community-dwelling older adults that were most vulnerable to adverse health outcomes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Deficit accumulation frailty or index frailty was developed around a conceptual framework that identifies the most frail, vulnerable older adults through cumulative comorbidities and cumulative illnesses as frail.
        </p>
        <p>
        </p>
        <p>
         In both physical frailty and deficit accumulation frailty, advanced frailty is consistent with advanced vulnerability. Indeed, comparability studies have found that those who are most vulnerable can be found by either tool. However, substantial discordance at individual level classifications exists between the conceptual frameworks in the more intermediate levels of frailty [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Acceptance of a standardized definition for frailty in clinical practice has been slowed in part by a proliferation of frailty measurement tools with differing conceptual bases and that often fail to differentiate between disability, comorbidity, and frailty. A summary of conceptual commonalities includes [
         <a href="#rid18">
          18,19,21,22
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple factors (medical, environmental, educational, and psychological background) impact frailty, functional status and physiologic reserve among older adults.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age, chronic comorbidities, and disability, while associated with frailty, do not establish the diagnosis of frailty [
         <a href="#rid1">
          1,22-24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frailty exists on a spectrum. The end stage of the continuum of frailty is often considered to be failure to thrive. (See
         <a class="medical medical_review" href="/z/d/html/3018.html" rel="external">
          "Failure to thrive in older adults: Evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3015.html" rel="external">
          "Failure to thrive in older adults: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Old age itself does not define frailty. Many older adults remain vigorous, despite advanced age, while others have gradual yet unrelenting functional decline in the absence of apparent disease states, or failure to rebound following illness or hospitalization.
        </p>
        <p class="headingAnchor" id="H2928682558">
         <span class="h2">
          Instruments developed to identify frailty
         </span>
         <span class="headingEndMark">
          —
         </span>
         Efforts to incorporate frailty measurement tools into both subspecialty and primary care practices continue to increase [
         <a href="#rid25">
          25,26
         </a>
         ]. Over the past several years, multiple frailty assessment tools have been developed to help identify frail patients. Most have been validated in their ability to identify those individuals at highest risk for adverse health outcomes in a variety of clinical settings.
        </p>
        <p>
         A 2016 comprehensive review of the most frequently cited frailty measurement tools identified 67 different frailty instruments, capturing varying domains and criteria depending upon the intended use of the instrument [
         <a href="#rid27">
          27
         </a>
         ]. A subsequent study found a wide range of agreement (no agreement to almost complete agreement) among these instruments when tested in the same population [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         The majority of screening tools used to determine frailty status have been developed based upon one of two concepts: "physical" or "phenotypic" frailty versus "deficit accumulation" or "index" frailty [
         <a href="#rid25">
          25,29,30
         </a>
         ] (see
         <a class="local">
          'Overview'
         </a>
         above). Physical or phenotypic frailty is thought to result from multisystem biological decline leading to specific symptoms such as weight loss, weakness, and walking speed. Deficit accumulation or index frailty is measured by tabulating the combination of comorbidities, social situations, and disabilities (rather than a specific biology per se) to assess risk.
        </p>
        <p>
         The physical frailty screening tool most often cited is often called the Fried Frailty Tool or Frailty Phenotype [
         <a href="#rid27">
          27
         </a>
         ]. This tool was developed to identify physical frailty in community-dwelling older adults and was validated in the Cardiovascular Health Study (CHS), which involved over 5000 men and women aged ≥65 years [
         <a href="#rid1">
          1
         </a>
         ], and multiple other studies [
         <a href="#rid11">
          11,12,31,32
         </a>
         ]. This tool requires patient participation and specialized equipment for grip strength and walking speed measurements and defines the frailty phenotype as meeting three or more of the following five criteria [
         <a href="#rid1">
          1
         </a>
         ]. Pre-frailty is defined as one or two of these characteristics, and not frail as having none:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weight loss (≥5 percent of body weight in last year)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exhaustion (positive response to questions regarding effort required for activity)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weakness (decreased grip strength)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Slow walking speed (gait speed) (&gt;6 to 7 seconds to walk 15 feet)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased physical activity (Kcals spent per week: males expending &lt;383 Kcals and females &lt;270 Kcal)
        </p>
        <p>
        </p>
        <p>
         The deficit accumulation or index approach to measuring frailty is based on the accumulation of illnesses, functional and cognitive declines, and social situations that are added together to calculate frailty [
         <a href="#rid33">
          33
         </a>
         ]. It requires answering 20 or more medical and functional-related questions. The higher the number of deficits, the higher the frailty score. The tool can be adapted to information available in the medical record and does not require a patient interview or exam for tabulation.
        </p>
        <p>
         Although there may be biological connections between mild cognitive impairment/dementia and frailty, the most commonly utilized physical frailty measurement tools do not incorporate cognitive assessment [
         <a href="#rid34">
          34
         </a>
         ]. However, frailty is associated with an increased risk of cognitive decline [
         <a href="#rid35">
          35,36
         </a>
         ]. In addition, the presence of cognitive impairment increases the likelihood of adverse health outcomes in geriatric patients who meet criteria for physical frailty. In a 2011 systematic review of 22 articles addressing the definition of frailty, cognitive measurements were commonly included in frailty screening, mostly in tools assessing frailty based on cumulative deficits rather than physical frailty [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2166124433">
         <span class="h2">
          Rapid screening tools
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the frailty phenotype assessment and the frailty index approach are the most commonly cited and most validated approaches to frailty measurement, clinicians and patients may benefit from using a quicker frailty screening assessment tool. Such tools allow clinicians to more quickly flag vulnerable older adults and work to alter care plans based on this vulnerability. Several studies have compared the most commonly utilized screening tools and found that these indices were comparable in predicting risk of adverse health outcomes and mortality [
         <a href="#rid2">
          2,37,38
         </a>
         ].
        </p>
        <p>
         In addition, several of the rapid screening tools described below can be utilized to identify those who might need a more formal comprehensive geriatric assessment (CGA) [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         A tool that takes only minutes to perform, and can be incorporated into the history-taking part, is the FRAIL scale, which is presented in a slightly modified version below [
         <a href="#rid40">
          40,41
         </a>
         ]. The mnemonic "FRAIL" is helpful in remembering the component questions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          F
         </strong>
         atigue ("Have you felt fatigued? Most or all of the time over the past month?") Yes = 1, No = 0
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          R
         </strong>
         esistance ("Do you have difficulty climbing a flight of stairs?") Yes = 1, No = 0
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          A
         </strong>
         mbulation ("Do you have difficulty walking one block?") Yes = 1, No = 0
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          I
         </strong>
         llnesses (“Do you have any of these illnesses: hypertension, diabetes, cancer (other than a minor skin cancer), chronic lung disease, heart attack, congestive heart failure, angina, asthma, arthritis, stroke, and kidney disease?”) Five or greater = 1, fewer than 5 = 0
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          L
         </strong>
         oss of weight (“Have you lost more than 5 percent of your weight in the past year?”) Yes= 1, No = 0
        </p>
        <p>
        </p>
        <p>
         Frail scale scores range from 0 to 5 (0 = best, 5 = worst) and represent frail (3 to 5), pre-frail (1 to 2), and robust (0) health status.
        </p>
        <p>
         Another assessment tool known for its ease in administering in most clinical settings is The Study of Osteoporotic Fractures (SOF) frailty tool [
         <a href="#rid37">
          37
         </a>
         ]. Frailty is defined as the presence of at least two of three components:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weight loss of 5 percent in last year;
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inability to rise from a chair five times without use of arms; or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A "no" response to the question "Do you feel full of energy?"
        </p>
        <p>
        </p>
        <p>
         The Edmonton Frail Scale has 14 questions that cover a variety of important domains, including cognition, general health, function, social support, and nutrition. This validated tool, while not diagnosing physical frailty or deficit accumulation frailty per se, is useful to identify a number of measurement domains that are important to the health care of older adults [
         <a href="#rid42">
          42
         </a>
         ]. Indeed, this tool functions like a short version of a CGA, which in turn may be helpful in the identification of more areas that may benefit from further diagnostic efforts or care management plans.
        </p>
        <p>
         Finally, the Clinical Frailty Scale is a rapid frailty screening tool that is scored between 1 (very fit) and 9 (terminally ill) based on self-report of comorbidities and the need for help with activities of daily living (ADLs) (
         <a class="graphic graphic_figure graphicRef129047" href="/z/d/graphic/129047.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H598976126">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is increasing evidence that dysregulated stress response systems, including immune, endocrine, and energy response systems are important to the development of physical or syndromic frailty. The basis of this dysregulation and ultimately frailty is hypothesized to be driven by aging-related molecular changes, genetics, chronic environmental exposures, and specific disease states (
         <a class="graphic graphic_figure graphicRef60373" href="/z/d/graphic/60373.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid44">
          44
         </a>
         ]. Sarcopenia, or age-related loss of skeletal muscle and muscle strength, is a key physiologic component of frailty. Decline in skeletal muscle function and mass are often consequences of age-related hormonal changes [
         <a href="#rid45">
          45-48
         </a>
         ] and changes in inflammatory pathways, including increase in inflammatory cytokines [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H598976279">
         <span class="h2">
          Endocrine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple age-related hormone changes have been associated with frailty (see
         <a class="medical medical_review" href="/z/d/html/6641.html" rel="external">
          "Growth hormone deficiency in adults"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased growth hormone and insulin-like growth factor (IGF)-1 [
         <a href="#rid45">
          45,50,51
         </a>
         ] – Associated with lower strength and decreased mobility in a cohort of community-dwelling older women [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased dehydroepiandrosterone sulfate (DHEA-S) [
         <a href="#rid45">
          45
         </a>
         ] – DHEA-S likely plays a direct role in maintaining muscle mass and indirectly prevents the activation of inflammatory pathways that contribute to muscle decline [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased cortisol levels [
         <a href="#rid54">
          54
         </a>
         ] – May impact skeletal muscle and immune system components.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased sex steroids – Evidence is mixed that lower levels of reproductive hormones contribute to frailty [
         <a href="#rid55">
          55-58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased 25(OH) vitamin D [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H598976552">
         <span class="h2">
          Inflammation and the immune system
         </span>
         <span class="headingEndMark">
          —
         </span>
         Direct biological connections between chronic exposure to inflammatory mediators and pathophysiological tissues changes consistent with frailty are increasingly evident.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum levels of the proinflammatory cytokine interleukin (IL) 6 and C-reactive protein (CRP), as well as white blood cell and monocyte counts, are elevated in community-dwelling frail older adults [
         <a href="#rid45">
          45,59-62
         </a>
         ]. In addition, elevated levels of these biomarkers in female long-term care residents may predict worsening physical performance and gait speed 12 months later [
         <a href="#rid62">
          62
         </a>
         ]. IL-6 acts as a transcription factor and signal transducer that adversely impacts skeletal muscle, appetite, adaptive immune system function, and cognition [
         <a href="#rid63">
          63
         </a>
         ] and contributes to anemia [
         <a href="#rid64">
          64,65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immune system activation may trigger the clotting cascade, with a demonstrated association between frailty and clotting markers (factor VIII, fibrinogen and D-dimer) [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frail older adults are less likely to mount an adequate immune response to influenza vaccination [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H598976755">
         <span class="h2">
          Other stress response and metabolic systems
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered glucose metabolism [
         <a href="#rid66">
          66
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dysregulation of the autonomic nervous system [
         <a href="#rid67">
          67
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age-related changes in the renin-angiotensin system and in mitochondria likely impact sarcopenia and inflammation, important components of frailty [
         <a href="#rid68">
          68
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H598978284">
         <span class="h1">
          PATIENT EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H598978298">
         <span class="h2">
          Patient history and examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Identification of frailty in a variety of clinical practice settings can guide additional assessment and aid in designing appropriate treatment plans.
        </p>
        <p>
         A consensus group of delegates from international and US societies has recommended that all persons over age 70 and adults with chronic disease or weight loss exceeding 5 percent over a year be screened for frailty using available screening tools [
         <a href="#rid19">
          19
         </a>
         ]. However, there are no available data from trials investigating whether screening an unselected geriatric population for frailty, based on age alone, will improve outcomes.
        </p>
        <p>
         For patients in whom frailty is a potential concern, based on the clinician's observations and reports from the patient and patient's family related to activity levels, diet, cognition, and weight, the following should be ascertained:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The patient history should focus on energy levels and excessive fatigue, ability to perform or maintain physical activities like stair climbing, and the ability to get out of the home and walk at least one block.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In addition to examination appropriate to the patient's medical history and current complaints, the physical examination should include a frailty screen such as those listed above and an assessment of the patient's ability to rise from a firm chair five times without use of arms, and the ability to walk across the room. Several frailty screening tools are available. (See
         <a class="local">
          'Instruments developed to identify frailty'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H598978305">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         When considering the diagnosis of frailty, it is crucial to develop a differential diagnosis list and rule out underlying medical or psychological issues that may be driving signs and symptoms of frailty.
        </p>
        <p>
         The most common conditions to be considered in older patients presenting with weight loss, weakness, and impaired functional abilities include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancy – Lymphoma, multiple myeloma, occult solid tumors
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rheumatologic disease – Polymyalgia rheumatica, vasculitis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Endocrinologic disease – Hyper- or hypothyroidism, diabetes mellitus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiovascular disease – Hypertension, heart failure, coronary artery disease, peripheral vascular disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal disease – Renal insufficiency
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hematologic disease – Myelodysplasia, iron deficiency, and pernicious anemia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nutritional deficits – Vitamin deficiencies
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neurologic disease – Parkinson disease, vascular dementia, serial lacunar infarcts
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7281713">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         When evaluating a frail patient for the first time, laboratory testing should be undertaken in order to rule out treatable conditions. A suggested initial screen includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basic metabolic panel
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver biochemical tests, including albumin
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vitamin B12
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vitamin D
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thyroid-stimulating hormone (TSH)
        </p>
        <p>
        </p>
        <p>
         Consideration of workup for other conditions, such as polymyalgia rheumatica, vasculitis, or congestive heart failure, should be based on the patient history and physical examination. (See
         <a class="medical medical_review" href="/z/d/html/8235.html" rel="external">
          "Clinical manifestations and diagnosis of polymyalgia rheumatica"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8226.html" rel="external">
          "Overview of and approach to the vasculitides in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H598978318">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specific care plans for frailty have not yet been extensively developed or tested. Despite this, there are emerging strategies that can be utilized to help mitigate the daily impact of frailty on quality of life and overall health status.
        </p>
        <p class="headingAnchor" id="H598978325">
         <span class="h2">
          Establishing goals of care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Goal-setting with patients and their families is crucial in providing care for the frail individual, establishing individual priorities, weighing risks and benefits of interventions, and making decisions regarding aggressiveness of care. As the older adult progresses along the frailty spectrum and develops more severe disease and/or disability, it becomes increasingly important to tailor medical care to the needs of these vulnerable patients while keeping the individual's values and goals in mind. Comprehensive geriatric assessment (CGA) may help guide development of management and intervention plans for frail patients [
         <a href="#rid39">
          39
         </a>
         ]. Potential interventions that might be beneficial along the continuum of frailty are shown in a figure (
         <a class="graphic graphic_figure graphicRef59326" href="/z/d/graphic/59326.html" rel="external">
          figure 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/95552.html" rel="external">
          "Discussing goals of care"
         </a>
         and
         <a class="local">
          'Comprehensive geriatric assessment'
         </a>
         below.)
        </p>
        <p>
         For robust older patients, the medical practitioner should appropriately treat known chronic diseases, manage intermittent acute illness and events, and assure age-appropriate screening measures and preventive care [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         In the moderately to severely frail patient, often "less is more." Aggressive screening or intervention for non-life-threatening conditions may be rife with complications. Procedures or hospitalizations may bring about unnecessary burden and decreased quality of life to a patient who is already at great risk of morbidity and mortality [
         <a href="#rid70">
          70
         </a>
         ]. In some cases, referral to palliative care may be the most appropriate intervention. (See
         <a class="local">
          'Palliative care'
         </a>
         below.)
        </p>
        <p>
         Nonetheless, frail older adults may benefit from interventions targeting specific components of their frailty exam, and from CGA [
         <a href="#rid71">
          71,72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H598978332">
         <span class="h2">
          Interventions
         </span>
        </p>
        <p class="headingAnchor" id="H2247765305">
         <span class="h3">
          Efficacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of interventions, particularly those including exercise, appear promising in the prevention or reduction of frailty.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A systematic review of the effectiveness of interventions to prevent frailty in older adults summarized 21 randomized trials with a total of 5275 older adults and 33 interventions [
         <a href="#rid73">
          73
         </a>
         ]. The results showed that group, but not individual, physical exercise programs were effective at reducing or postponing physical frailty as measured by any validated scale or measurement or index (eg, frailty index, physical frailty measures, or Edmonton Frailty Scale). Favorable effects of physical exercise, nutritional supplementation, and cognitive training were also seen on a variety of frailty components.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A secondary analysis of data from a three-year, randomized trial of 1637 French community-dwelling older adults investigated whether a long-term multi-domain lifestyle intervention of cognitive training, nutrition counseling, and advice on physical activity was associated with severity and incidence of frailty measured by a comorbidity or deficit accumulation index [
         <a href="#rid74">
          74
         </a>
         ]. Compared with usual care, the intervention group had a decreased risk of both developing increased numbers of comorbidities (hazard ratio [HR] 0.72; 95% CI 0.55-0.93) and of persistent comorbidities/deficits (HR 0.53; 95% CI 0.33-0.85).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H598978339">
         <span class="h3">
          Exercise
         </span>
         <span class="headingEndMark">
          —
         </span>
         The benefits of exercise in older adults include increased mobility, enhanced performance of activities of daily living (ADLs), improved gait, decreased falls, improved bone mineral density, and increased general wellbeing [
         <a href="#rid75">
          75-78
         </a>
         ]. Studies suggest that even the frailest older adults are likely to benefit from physical activity at almost any level that can be safely tolerated [
         <a href="#rid79">
          79,80
         </a>
         ]. In a systematic review of 33 trials conducted among adults over 65 years of age, yoga improved the frailty markers of gait speed, and lower extremity strength and endurance when compared with education or inactive controls [
         <a href="#rid81">
          81
         </a>
         ]. Yoga outcomes were similar to those seen with the active controls of Tai chi or other forms of exercise. While functionally limited or frail individuals may never be able to meet minimum recommended activity levels for older adults, even modest activity and muscle strengthening can impact the progression of functional limitations [
         <a href="#rid79">
          79,80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16524.html" rel="external">
          "Physical activity and exercise in older adults", section on 'Functionally limited or frail'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3101897454">
         <span class="h3">
          Occupational therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to exercise, formal occupational therapy has been shown to be helpful, particularly in patients who are having difficulties with ADLs. A meta-analysis of home and community-based occupational therapy for frail older adults showed moderate improvements in the ability to perform ADLs, in social participation, and in mobility, compared with baseline [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H598979621">
         <span class="h3">
          Nutritional supplementation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with weight loss as a component of frailty, attention should be focused on medication side effects, depression, difficulties with chewing and swallowing, dependency on others for eating, and use of unnecessary dietary restrictions (low-salt/low-fat) (
         <a class="graphic graphic_table graphicRef54156" href="/z/d/graphic/54156.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3015.html" rel="external">
          "Failure to thrive in older adults: Management", section on 'Weight loss'
         </a>
         .)
        </p>
        <p>
         In treatment of weight loss, oral nutritional supplements between meals (low-volume, high caloric drinks or puddings) may be helpful in adding protein and calories. A meta-analysis of studies of nutritional supplements showed that providing nutritional supplements to older undernourished adults yielded small gains in weight (2.2 percent) [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p>
         Several meta-analyses of randomized trials show a reduction in falls with vitamin D supplementation [
         <a href="#rid84">
          84-88
         </a>
         ]. Vitamin D supplementation also may improve balance and preserve muscle strength [
         <a href="#rid89">
          89
         </a>
         ] and may play a role in preventing or treating frailty. In one report, lower serum levels of 25-hydroxyvitamin D (&lt;20.0 ng/mL) were associated with a higher prevalence of frailty at baseline in a group of 1600 men over age 65 but did not predict greater risk for developing frailty at 4.6 years [
         <a href="#rid90">
          90
         </a>
         ]. Given that vitamin D appears to play an important role in both muscle and nervous tissue maintenance with aging, further studies to evaluate the association between vitamin D and frailty are indicated. The daily intake of vitamin D in older adults should be at least 800 to 1000 international units. (See
         <a class="medical medical_review" href="/z/d/html/3014.html" rel="external">
          "Falls: Prevention in community-dwelling older persons"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3017.html" rel="external">
          "Geriatric health maintenance", section on 'Vitamin D'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H598980190">
         <span class="h3">
          Medication review
         </span>
         <span class="headingEndMark">
          —
         </span>
         Periodic evaluation of a patient's drug regimen is an essential component of medical care for an older person, and it is especially important for patients who are pre-frail or frail. Such a review may indicate the need for changes to prescribed drug therapy (
         <a class="graphic graphic_table graphicRef52450" href="/z/d/graphic/52450.html" rel="external">
          table 2
         </a>
         ). Changes may include discontinuing a therapy prescribed for an indication that no longer exists, discontinuing therapy with side effects that may be contributing to frailty symptoms, substituting a therapy with a potentially safer agent, changing drug dose, or adding a new medication. In reviewing medications, it is important to focus on the established goals of care with the patient and caregivers. (See
         <a class="medical medical_review" href="/z/d/html/122694.html" rel="external">
          "Deprescribing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H598978346">
         <span class="h3">
          Ineffective interventions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although activation of inflammatory pathways and dysregulation in endocrine systems is believed to contribute to frailty (see
         <a class="local">
          'Pathophysiology'
         </a>
         above), there are limited data on hormonal and antiinflammatory interventions for frailty, and none have proven to be of significant benefit.
        </p>
        <p>
         Several hormonal and nutritional interventions have been evaluated in related geriatric conditions.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9981" href="/z/d/drug information/9981.html" rel="external">
          Testosterone
         </a>
         replacement increased muscle mass and strength in hypogonadal and eugonadal men, especially in combination with exercise. Testosterone, however, may lead to an unfavorable lipid profile and unpredictable effects on the prostate gland [
         <a href="#rid91">
          91,92
         </a>
         ]. We do not suggest routine testosterone replacement, in the absence of demonstrable hypogonadism, as evidenced by clinical symptoms and signs consistent with androgen deficiency and a subnormal morning (8 to 10 AM) serum testosterone concentration on three separate occasions. (See
         <a class="medical medical_review" href="/z/d/html/7461.html" rel="external">
          "Testosterone treatment of male hypogonadism", section on 'Appropriate candidates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Growth hormone or growth hormone releasing factor supplementation have not demonstrated efficacy in improving function or other clinical outcomes in older adults with age-related declines [
         <a href="#rid93">
          93
         </a>
         ]. A systematic review found that the risks of exogenous growth hormone outweigh potential benefits [
         <a href="#rid94">
          94
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Benefit from dehydroepiandrosterone sulfate (DHEA-S) supplementation in preventing or treating frailty has not been demonstrated [
         <a href="#rid95">
          95-97
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Further intervention studies in frailer, older individuals will be needed to determine the effectiveness and potential harm of treatments that target endocrine or inflammatory biology in frail older adults.
        </p>
        <p class="headingAnchor" id="H598978353">
         <span class="h2">
          Palliative care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnosing frailty helps identify those older adults at highest risk of adverse health outcomes. Palliative care approaches may be helpful to alleviate symptoms of related medical conditions and to help in consideration of the appropriateness of potential medical and surgical interventions (such as chemotherapy or major surgery) and their impact on mortality and quality of life for the frail older adult [
         <a href="#rid98">
          98
         </a>
         ].
        </p>
        <p>
         For those with advanced frailty and multiple comorbidities or those with failure to thrive, the engagement of a palliative care team may help to identify methods to preserve or improve quality of life and to clarify goals of care. (See
         <a class="medical medical_review" href="/z/d/html/14240.html" rel="external">
          "Benefits, services, and models of subspecialty palliative care", section on 'Palliative care services'
         </a>
         .)
        </p>
        <p>
         Notably, in the United States, the Centers for Medicare and Medicaid Services (CMS) no longer accept either debility or adult failure to thrive as a principal diagnosis for hospice services, and these diagnoses should not be listed as the primary hospice diagnosis. However, progressive inanition is one criterion which may be used to identify a likely life expectancy of six months or less. (See
         <a class="medical medical_review" href="/z/d/html/2200.html" rel="external">
          "Hospice: Philosophy of care and appropriate utilization in the United States"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H598979896">
         <span class="h1">
          MODEL SYSTEMS OF CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Care for frail older adults is frequently challenging, related to their increased disability and multiple chronic diseases. This is further heightened in frail individuals who lack social supports. An interdisciplinary team-based approach to care is often important in meeting the needs of frail adults, who may represent the population most likely to benefit from specialized and targeted comprehensive interventions [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
         Outcomes of interdisciplinary interventions are mixed, however. In one small randomized trial, an interdisciplinary intervention involving screening, home visits, and occupational and physical therapy tailored to the patient's support needs, compared with usual care, resulted in no difference in disability outcome at six-month, one-year, and two-year assessments [
         <a href="#rid100">
          100
         </a>
         ]. However, in another randomized clinical trial, multidisciplinary approaches that focused on improvement of specific diagnostic criteria for physical frailty resulted in improvement in frailty status and the potential for reduced health care costs [
         <a href="#rid71">
          71,101
         </a>
         ].
        </p>
        <p>
         A conceptual model of care has been outlined by one gerontology group, that proposes several adjuncts and enhancements to the traditional one clinician/one patient visit [
         <a href="#rid102">
          102
         </a>
         ]. Proposed practice changes include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comanagement involving clinician and nurse practitioner or clinician assistant
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Support personnel (nurses, social workers) with specialized gerontology training available as consultants
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facilities accommodations – Adjustable height tables, clearance for wheelchair maneuvering, microphones/headsets for hearing impaired, adjustable walker
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         General staff education for communicating with frail older adults
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Team meetings to discuss complicated patients
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Full integration of electronic communications – Electronic medical records, email, secure practice website, patient health questionnaires, templated notes
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Partnership and familiarity with community resources for housing, health promotion, and caregiver support
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H598979951">
         <span class="h2">
          Comprehensive geriatric assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Frail older adults are at highest risk in the general population of older adults, and may be expected to derive maximum benefit from comprehensive geriatric assessment (CGA). The overall goals of CGA are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To improve physical and psychological function
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To optimize medication prescribing and use
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To decrease nursing home placement, hospitalization, mortality risk
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To improve patient satisfaction
        </p>
        <p>
        </p>
        <p>
         CGA involves an interdisciplinary care team that coordinates evaluation of an older patient and develops a plan for integrated care [
         <a href="#rid103">
          103
         </a>
         ]. The team usually consists of a geriatrician or other medical practitioner knowledgeable in the care of older adults, nurse, social worker, pharmacist, and an occupational or physical therapist. (See
         <a class="medical medical_review" href="/z/d/html/3009.html" rel="external">
          "Comprehensive geriatric assessment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2808.html" rel="external">
          "Comprehensive geriatric assessment for patients with cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H598979983">
         <span class="h2">
          Outpatient PACE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The frailest older adults in the United States may benefit from the Medicare Program of All-inclusive Care for the Elderly (PACE). The goals of this model are to improve function, overcome environmental challenges, and keep older adults living in their communities by preventing institutionalization.
        </p>
        <p>
         In this outpatient patient management model, primary care is delivered to community-dwelling older adults by an interdisciplinary team in a day clinic setting [
         <a href="#rid104">
          104
         </a>
         ]. The interdisciplinary team includes a practitioner knowledgeable in geriatric medicine, nurses, physical and occupational therapists, and social workers. Services provided include home nursing, physical and occupational therapy, transportation, aide service, and adult day care. Patients who enter the program receive complete long-term care and are followed until the end of their lives, even if they eventually require placement in an assisted-living facility or nursing home.
        </p>
        <p>
         PACE was designated as a permanent Medicare program in 1997 because it was successful in maintaining function and community-dwelling status and in providing lower-cost care compared with traditional fee-for-service care [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H598980017">
         <span class="h2">
          Hospital care and ACE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hospitalization increases risk for institutionalization and decrease in quality of life for a frail older adult. Change in environment, exposure to new medications, and immobility, combined with acute illness, can lead to devastating outcomes for these vulnerable patients. Often, the decline in level of function and ability to care for oneself that occurs during hospitalization persists after discharge [
         <a href="#rid106">
          106,107
         </a>
         ]. In one study, frail individuals had a sevenfold increased risk of progressing from no disability to mild disability within one month of hospitalization, compared with non-frail patients (35 versus 7 percent) [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p>
         Acute Care for Elders (ACE) is a model of care for the acutely ill hospitalized older adult designed to prevent functional decline and improve functional independence if decline has occurred. The model typically includes a specially designed environment that is a more home-like environment, patient-centered medical care that focuses on the prevention of disability, and comprehensive discharge planning and management. In a randomized controlled trial of 1531 community-dwelling adults aged 70 and older, this model decreased the likelihood of decline in activities of daily living (ADLs) or nursing home placement both at hospital discharge and at 12 months without an increase in hospital length of stay or hospital costs [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Frailty is an increasingly recognized clinical state of vulnerability with inherent increased risk for adverse health outcomes, including functional decline and mortality. There is no gold standard for diagnosing frailty. Importantly, old age itself does not define frailty. (See
         <a class="local">
          'Concepts and definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The physiological basis of frailty is thought to be driven in part by the activation of inflammatory pathways and dysregulation of neuroendocrine systems, which leads to skeletal muscle decline. (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An international consensus group has recommended that all persons over age 70, and adults with chronic disease or weight loss exceeding 5 percent over a year, be screened for frailty, though evidence supporting this approach is not robust. The FRAIL scale is one tool that can be readily incorporated into history-taking, but multiple other screening tools are available and have been validated. Physical examination should include assessment of the patient's ability to rise from a firm chair five times without use of arms and their ability to walk across the room. (See
         <a class="local">
          'Patient evaluation'
         </a>
         above and
         <a class="local">
          'Instruments developed to identify frailty'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Goal-setting with patients and their families is crucial in providing care for the frail individual, establishing individual priorities, weighing risks and benefits of interventions, and making decisions regarding aggressiveness of care. Interventions have focused on components of frailty, such as strength. Activity interventions have been shown to have a positive impact on even the frailest older adults. To date, no biological or pharmaceutical interventions are recommended for frailty per se, although biologically targeted interventions may play a role in the future. (See
         <a class="local">
          'Establishing goals of care'
         </a>
         above and
         <a class="local">
          'Interventions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A variety of interventions, particularly those including exercise, appear promising in the prevention or reduction of frailty. However, it is important to tailor interventions to the individual, incorporating patient preferences and stage on the spectrum of frailty (
         <a class="graphic graphic_figure graphicRef59326" href="/z/d/graphic/59326.html" rel="external">
          figure 3
         </a>
         ). Palliative care approaches may be considered in the frailest subset of older adults. (See
         <a class="local">
          'Interventions'
         </a>
         above and
         <a class="local">
          'Palliative care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical geriatric evaluation teams and specialized programs can play an important role in improving the quality of life for older adults. (See
         <a class="local">
          'Model systems of care'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiely DK, Cupples LA, Lipsitz LA. Validation and comparison of two frailty indexes: The MOBILIZE Boston Study. J Am Geriatr Soc 2009; 57:1532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci 2006; 61:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woods NF, LaCroix AZ, Gray SL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005; 53:1321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cawthon PM, Marshall LM, Michael Y, et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007; 55:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 2015; 26:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 2012; 60:1487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc 2013; 61:1537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee DR, Kawas CH, Gibbs L, Corrada MM. Prevalence of Frailty and Factors Associated with Frailty in Individuals Aged 90 and Older: The 90+ Study. J Am Geriatr Soc 2016; 64:2257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013; 381:752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010; 210:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garonzik-Wang JM, Govindan P, Grinnan JW, et al. Frailty and delayed graft function in kidney transplant recipients. Arch Surg 2012; 147:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim DH, Kim CA, Placide S, et al. Preoperative Frailty Assessment and Outcomes at 6 Months or Later in Older Adults Undergoing Cardiac Surgical Procedures: A Systematic Review. Ann Intern Med 2016; 165:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Pederson JL, Churchill TA, et al. Impact of frailty on outcomes after discharge in older surgical patients: a prospective cohort study. CMAJ 2018; 190:E184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothenberg KA, Stern JR, George EL, et al. Association of Frailty and Postoperative Complications With Unplanned Readmissions After Elective Outpatient Surgery. JAMA Netw Open 2019; 2:e194330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoogendijk EO, Stolz E, Oude Voshaar RC, et al. Trends in Frailty and Its Association With Mortality: Results From the Longitudinal Aging Study Amsterdam, 1995-2016. Am J Epidemiol 2021; 190:1316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuffel RL, Morin RT, Covinsky KE, et al. Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older. JAMA Psychiatry 2023; 80:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodríguez-Mañas L, Féart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2013; 68:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xue QL, Tian J, Walston JD, et al. Discrepancy in Frailty Identification: Move Beyond Predictive Validity. J Gerontol A Biol Sci Med Sci 2020; 75:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sternberg SA, Wershof Schwartz A, Karunananthan S, et al. The identification of frailty: a systematic literature review. J Am Geriatr Soc 2011; 59:2129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130:945.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newman AB, Gottdiener JS, Mcburnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56:M158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walston J. Frailty--the search for underlying causes. Sci Aging Knowledge Environ 2004; 2004:pe4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson TN, Walston JD, Brummel NE, et al. Frailty for Surgeons: Review of a National Institute on Aging Conference on Frailty for Specialists. J Am Coll Surg 2015; 221:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walston J, Robinson TN, Zieman S, et al. Integrating Frailty Research into the Medical Specialties-Report from a U13 Conference. J Am Geriatr Soc 2017; 65:2134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev 2016; 26:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aguayo GA, Donneau AF, Vaillant MT, et al. Agreement Between 35 Published Frailty Scores in the General Population. Am J Epidemiol 2017; 186:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walston JD, Bandeen-Roche K. Frailty: a tale of two concepts. BMC Med 2015; 13:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 2010; 58:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yao X, Hamilton RG, Weng NP, et al. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 2011; 29:5015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc 2008; 56:2211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007; 62:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avila-Funes JA, Amieva H, Barberger-Gateau P, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc 2009; 57:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyle PA, Buchman AS, Wilson RS, et al. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc 2010; 58:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson DA, Savva GM, Coen RF, Kenny RA. Cognitive function in the prefrailty and frailty syndrome. J Am Geriatr Soc 2014; 62:2118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ensrud KE, Ewing SK, Taylor BC, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008; 168:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ensrud KE, Ewing SK, Cawthon PM, et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 2009; 57:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner G, Clegg A, British Geriatrics Society, et al. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing 2014; 43:744.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012; 16:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woo J, Yu R, Wong M, et al. Frailty Screening in the Community Using the FRAIL Scale. J Am Med Dir Assoc 2015; 16:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rolfson DB, Majumdar SR, Tsuyuki RT, et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006; 35:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006; 54:991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leng SX, Cappola AR, Andersen RE, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 2004; 16:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valenti G, Denti L, Maggio M, et al. Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang H, Casaburi R, Taylor WE, et al. Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients. Kidney Int 2005; 68:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morley JE, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med 2001; 137:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009; 64:1183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nass R, Thorner MO. Impact of the GH-cortisol ratio on the age-dependent changes in body composition. Growth Horm IGF Res 2002; 12:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanfranco F, Gianotti L, Giordano R, et al. Ageing, growth hormone and physical performance. J Endocrinol Invest 2003; 26:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cappola AR, Xue QL, Ferrucci L, et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003; 88:2019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt M, Naumann H, Weidler C, et al. Inflammation and sex hormone metabolism. Ann N Y Acad Sci 2006; 1069:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varadhan R, Walston J, Cappola AR, et al. Higher levels and blunted diurnal variation of cortisol in frail older women. J Gerontol A Biol Sci Med Sci 2008; 63:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poehlman ET, Toth MJ, Fishman PS, et al. Sarcopenia in aging humans: the impact of menopause and disease. J Gerontol A Biol Sci Med Sci 1995; 50 Spec No:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Donnell AB, Araujo AB, McKinlay JB. The health of normally aging men: The Massachusetts Male Aging Study (1987-2004). Exp Gerontol 2004; 39:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travison TG, Nguyen AH, Naganathan V, et al. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metab 2011; 96:2464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohr BA, Bhasin S, Kupelian V, et al. Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc 2007; 55:548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puts MT, Visser M, Twisk JW, et al. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 2005; 63:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162:2333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leng SX, Xue QL, Tian J, et al. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women's Health and Aging Studies I. Exp Gerontol 2009; 44:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langmann GA, Perera S, Ferchak MA, et al. Inflammatory Markers and Frailty in Long-Term Care Residents. J Am Geriatr Soc 2017; 65:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000; 51:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc 2003; 51:S18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002; 50:1268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalyani RR, Varadhan R, Weiss CO, et al. Frailty status and altered glucose-insulin dynamics. J Gerontol A Biol Sci Med Sci 2012; 67:1300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varadhan R, Chaves PH, Lipsitz LA, et al. Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices. J Gerontol A Biol Sci Med Sci 2009; 64:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burks TN, Andres-Mateos E, Marx R, et al. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 2011; 3:82ra37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldberg TH, Chavin SI. Preventive medicine and screening in older adults. J Am Geriatr Soc 1997; 45:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285:2750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cameron ID, Fairhall N, Langron C, et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med 2013; 11:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin HC, Wang CH, Tsai FJ, et al. Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study. Diabetologia 2015; 58:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Apóstolo J, Cooke R, Bobrowicz-Campos E, et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep 2018; 16:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Souto Barreto P, Rolland Y, Maltais M, et al. Associations of Multidomain Lifestyle Intervention with Frailty: Secondary Analysis of a Randomized Controlled Trial. Am J Med 2018; 131:1382.e7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daley MJ, Spinks WL. Exercise, mobility and aging. Sports Med 2000; 29:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spirduso WW, Cronin DL. Exercise dose-response effects on quality of life and independent living in older adults. Med Sci Sports Exerc 2001; 33:S598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keysor JJ. Does late-life physical activity or exercise prevent or minimize disablement? A critical review of the scientific evidence. Am J Prev Med 2003; 25:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Province MA, Hadley EC, Hornbrook MC, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330:1769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller ME, Rejeski WJ, Reboussin BA, et al. Physical activity, functional limitations, and disability in older adults. J Am Geriatr Soc 2000; 48:1264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loewenthal J, Innes KE, Mitzner M, et al. Effect of Yoga on Frailty in Older Adults : A Systematic Review. Ann Intern Med 2023; 176:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Coninck L, Bekkering GE, Bouckaert L, et al. Home- and Community-Based Occupational Therapy Improves Functioning in Frail Older People: A Systematic Review. J Am Geriatr Soc 2017; 65:1863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009; :CD003288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM 2007; 100:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004; 291:1999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339:b3692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009; :CD007146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cameron ID, Murray GR, Gillespie LD, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010; :CD005465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 2005; 26:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ensrud KE, Blackwell TL, Cauley JA, et al. Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 2011; 59:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997; 278:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tenover JS. Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men. Baillieres Clin Endocrinol Metab 1998; 12:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamberts SW. The somatopause: to treat or not to treat? Horm Res 2000; 53 Suppl 3:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007; 146:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morley JE, Kim MJ, Haren MT. Frailty and hormones. Rev Endocr Metab Disord 2005; 6:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355:1647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A 2000; 97:4279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maida V, Devlin M. Frailty, thy name is Palliative! CMAJ 2015; 187:1312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ko FC. The clinical care of frail, older adults. Clin Geriatr Med 2011; 27:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metzelthin SF, van Rossum E, de Witte LP, et al. Effectiveness of interdisciplinary primary care approach to reduce disability in community dwelling frail older people: cluster randomised controlled trial. BMJ 2013; 347:f5264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fairhall N, Sherrington C, Kurrle SE, et al. Economic evaluation of a multifactorial, interdisciplinary intervention versus usual care to reduce frailty in frail older people. J Am Med Dir Assoc 2015; 16:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ganz DA, Fung CH, Sinsky CA, et al. Key elements of high-quality primary care for vulnerable elders. J Gen Intern Med 2008; 23:2018.
          </a>
         </li>
         <li class="breakAll">
          Urdangarin CF. Comprehensive Geriatric Assessment and Management. In: Assessing Older Persons, Kane RL, Kane RA (Eds), Oxford University Press, New York 2000.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eng C, Pedulla J, Eleazer GP, et al. Program of All-inclusive Care for the Elderly (PACE): an innovative model of integrated geriatric care and financing. J Am Geriatr Soc 1997; 45:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mukamel DB, Peterson DR, Temkin-Greener H, et al. Program characteristics and enrollees' outcomes in the Program of All-Inclusive Care for the Elderly (PACE). Milbank Q 2007; 85:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palmer RM, Counsell S, Landefeld CS. Clinical intervention trials: the ACE unit. Clin Geriatr Med 1998; 14:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sager MA, Franke T, Inouye SK, et al. Functional outcomes of acute medical illness and hospitalization in older persons. Arch Intern Med 1996; 156:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gill TM, Allore HG, Gahbauer EA, Murphy TE. Change in disability after hospitalization or restricted activity in older persons. JAMA 2010; 304:1919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Counsell SR, Holder CM, Liebenauer LL, et al. Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc 2000; 48:1572.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3010 Version 51.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11253156" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Frailty in older adults: evidence for a phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19682112" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Validation and comparison of two frailty indexes: The MOBILIZE Boston Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16567375" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Phenotype of frailty: characterization in the women's health and aging studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16078957" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17661960" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Frailty in older men: prevalence, progression, and relationship with mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25403592" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The prevalence and outcomes of frailty in older cancer patients: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22881367" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Prevalence of frailty in community-dwelling older persons: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24028357" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27590837" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prevalence of Frailty and Factors Associated with Frailty in Individuals Aged 90 and Older: The 90+ Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23395245" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Frailty in elderly people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20510798" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Frailty as a predictor of surgical outcomes in older patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22351919" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Frailty and delayed graft function in kidney transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27548070" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Preoperative Frailty Assessment and Outcomes at 6 Months or Later in Older Adults Undergoing Cardiac Surgical Procedures: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29565018" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Impact of frailty on outcomes after discharge in older surgical patients: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31125103" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Association of Frailty and Postoperative Complications With Unplanned Readmissions After Elective Outpatient Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33534876" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Trends in Frailty and Its Association With Mortality: Results From the Longitudinal Aging Study Amsterdam, 1995-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36811913" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22511289" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23764209" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Frailty consensus: a call to action.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30789645" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Discrepancy in Frailty Identification: Move Beyond Predictive Validity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22091630" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The identification of frailty: a systematic literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10375351" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Toward an understanding of frailty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11253157" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Associations of subclinical cardiovascular disease with frailty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14749522" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Frailty--the search for underlying causes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26422746" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Frailty for Surgeons: Review of a National Institute on Aging Conference on Frailty for Specialists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28422280" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Integrating Frailty Research into the Medical Specialties-Report from a U13 Conference.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26674984" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28633404" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Agreement Between 35 Published Frailty Scores in the General Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26265077" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Frailty: a tale of two concepts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20345864" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21565245" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19093920" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Prognostic significance of potential frailty criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17634318" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Frailty in relation to the accumulation of deficits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19245415" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20070417" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Physical frailty is associated with incident mild cognitive impairment in community-based older persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25370593" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Cognitive function in the prefrailty and frailty syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18299493" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19245414" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25336440" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22836700" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25732832" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Frailty Screening in the Community Using the FRAIL Scale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16757522" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Validity and reliability of the Edmonton Frail Scale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16129869" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : A global clinical measure of fitness and frailty in elderly people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16776798" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15195991" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15123757" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15954927" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11283518" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Sarcopenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19622801" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12162996" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Impact of the GH-cortisol ratio on the age-dependent changes in body composition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14964439" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Ageing, growth hormone and physical performance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12727948" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16855150" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Inflammation and sex hormone metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18314456" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Higher levels and blunted diurnal variation of cortisol in frail older women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7493223" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Sarcopenia in aging humans: the impact of menopause and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15236757" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : The health of normally aging men: The Massachusetts Male Aging Study (1987-2004).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21677041" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17397433" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Testosterone, sex hormone-binding globulin, and frailty in older men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16181232" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Endocrine and inflammatory markers as predictors of frailty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12418947" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19457449" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women's Health and Aging Studies I.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28323342" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Inflammatory Markers and Frailty in Long-Term Care Residents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10774463" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12588568" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Biological interactions of aging and anemia: a focus on cytokines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12133023" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21873592" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Frailty status and altered glucose-insulin dynamics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19223607" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21562229" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9063282" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Preventive medicine and screening in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11386931" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Cancer screening in elderly patients: a framework for individualized decision making.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23497404" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25335440" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29324562" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29969614" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Associations of Multidomain Lifestyle Intervention with Frailty: Secondary Analysis of a Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10688279" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Exercise, mobility and aging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11427784" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Exercise dose-response effects on quality of life and independent living in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14552936" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Does late-life physical activity or exercise prevent or minimize disablement? A critical review of the scientific evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7715058" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8190152" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Exercise training and nutritional supplementation for physical frailty in very elderly people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11037014" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Physical activity, functional limitations, and disability in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36913687" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Effect of Yoga on Frailty in Older Adults : A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28369719" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Home- and Community-Based Occupational Therapy Improves Functioning in Frail Older People: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19370584" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Protein and energy supplementation in elderly people at risk from malnutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17308327" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15113819" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Effect of Vitamin D on falls: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19797342" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19370674" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Interventions for preventing falls in older people living in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20091578" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Interventions for preventing falls in older people in nursing care facilities and hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15811435" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21226680" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9334293" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : The endocrinology of aging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10332563" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10971103" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The somatopause: to treat or not to treat?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17227934" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Systematic review: the safety and efficacy of growth hormone in the healthy elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15843881" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Frailty and hormones.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17050889" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : DHEA in elderly women and DHEA or testosterone in elderly men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10760294" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26574002" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Frailty, thy name is Palliative!
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21093725" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : The clinical care of frail, older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24022033" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Effectiveness of interdisciplinary primary care approach to reduce disability in community dwelling frail older people: cluster randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25239014" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Economic evaluation of a multifactorial, interdisciplinary intervention versus usual care to reduce frailty in frail older people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18839261" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Key elements of high-quality primary care for vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18839261" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Key elements of high-quality primary care for vulnerable elders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9033525" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Program of All-inclusive Care for the Elderly (PACE): an innovative model of integrated geriatric care and financing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17718666" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Program characteristics and enrollees' outcomes in the Program of All-Inclusive Care for the Elderly (PACE).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9799482" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Clinical intervention trials: the ACE unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8629876" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Functional outcomes of acute medical illness and hospitalization in older persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21045098" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Change in disability after hospitalization or restricted activity in older persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11129745" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
